Harsh Desai MD
@harsh_desai_1
@UCIrvine Alum | @UToledoMed Alum | #Neurology Resident @neuroUCMC | Love to #eat and enjoy #nature | #mavicmini pilot | Married to @KavyaPaiMD | He/Him
ID: 1279014192109027328
03-07-2020 11:28:52
54 Tweet
262 Takipçi
254 Takip Edilen
Excited to start my journey at UChicago Neurology Residency after a year at NorthShore for IM! Thanks UToledo Neurology and UToledo Medicine for a great 4 years! #MatchDay2021 #matching2021
Happy to see my coresident Sachin A. Kothari pumping out new research! Kudos to everyone else on the team for their hard work!
Our new paper in journal of stroke! A living systematic review showing continuous benefit of EVT in patients presenting with large core! Timely with TESLA results Osama Zaidat MD Rami Z. Morsi, MD Mohamed Elfil, MD Hazem Ghaith, MD Sachin A. Kothari Harsh Desai MD Fawaz Al-Mufti, MD, FSVIN
Step by step illustration of accessing intracranial vessels with large bore access Zoom RDL catheter directly through radial artery drive.google.com/file/d/1YusYf0… Many thanks to our great team @sonamthind Harsh Desai MD Sachin A. Kothari Rami Z. Morsi, MD
🎉Publication alert 🎉 Excited to share with you all results from our latest article, titled "Intravenous cangrelor use for neuroendovascular procedures: a two-center experience and updated systematic review" in Frontiers - Neurology! doi.org/10.3389/fneur.… Tweetorial below (1/17)
Join UChicago Medicine's NeuroEndovascular Surgery e-Fellowship! Elevate your neurointerventional skills with 100+ live & recorded cases from world-class experts. Flexible online format. Earn CME. Apply now: cme.uchicago.edu/NSF25 #neurosurgery #medtwitter"
We are all so excited to be hosting our annual virtual open house on September 12th at 7PM CST! Be on the lookout for another post later this week with registration details! Bring all of your questions! 🧐☺️ @nmatch2025 UChicagoNeuro
🔥 off the press! Work from Sachin A. Kothari Rami Z. Morsi, MD Harsh Desai MD demonstrates that pre-hospital stroke screening forms perform similarly when used for LVOs and MeVOs-- though LAMS is the most discriminative. bit.ly/40zPHsi
🧵1/ 🚨 New study drop! We're excited to share our work comparing reduced-dose ticagrelor, full-dose ticagrelor, and clopidogrel for secondary prevention after acute stroke/TIA. Big thanks to Harsh Desai MD, Elena Badillo Goicoechea, and the entire team! sciencedirect.com/science/articl…